Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jeffrey B Folsom"'
Publikováno v:
Indian Journal of Urology, Vol 24, Iss 3, Pp 329-335 (2008)
Purpose: Initially conceived as an intervention for prostatic infection, injection therapy has been used to alleviate urinary retention, and is now primarily investigated for the treatment of lower urinary tract symptoms (LUTS) secondary to benign pr
Externí odkaz:
https://doaj.org/article/ce089030a6124c2da961db8710b7bb57
Publikováno v:
Current Prostate Reports. 2:89-95
A plethora of reports describe a number of promising new minimally invasive treatment modalities available to patients with chronic prostatitis. This article reviews these studies, with most evaluating treatments using heat or intraprostatic injectio
Autor:
Jeffrey B. Folsom, Adriana Moravčı́ková, Peter Zvara, Abbey Dattilio, Jan Kliment, Margaret A. Vizzard, Mark K. Plante
Publikováno v:
Brain Research. 1002:35-42
Nitric oxide (NO), a neurotransmitter in autonomic reflex pathways, plays a role in functional neuroregulation of the lower urinary tract. Upregulation of the levels of neuronal nitric oxide synthase (nNOS), the enzyme system responsible for NO synth
Autor:
Peter Zvara, Abbey Dattilio, Margaret A. Vizzard, Jeffrey B. Folsom, Vivian Y. Hu, Susan E. Malley
Publikováno v:
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 284:R574-R585
The purpose of this study was to determine the role of cyclooxygenase-2 (COX-2) and its metabolites in lower urinary tract function after induction of acute (4 h), intermediate (48 h), or chronic (10 day) cyclophosphamide (CYP)-induced cystitis. Blad
Publikováno v:
BJU international. 94(9)
OBJECTIVES To evaluate the location and extent of diffusion that occurs when liquid is injected transurethrally into the prostate gland, by correlating real-time fluoroscopy and gross pathology, and to quantify the variables that influence intraprost
Publikováno v:
The Journal of urology. 172(1)
Most men 50 to 80 years old will have development of some degree of benign prostatic hyperplasia (BPH). Many who experience lower urinary tract symptoms (LUTS) will be treated medically. However, significant numbers will have more severe and progress